Genetic Obesity
Metabolic·MeSH: Hyperphagia
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| aav-bdnf | MeiraGTx Holdings plc (MGTX) |
Frequently asked questions
How many drugs are in development for Genetic Obesity?
BioSniper tracks 1 drug in development for Genetic Obesity across 1 company.
How many clinical trials target Genetic Obesity?
There are 1 clinical trial targeting Genetic Obesity tracked by BioSniper.
What is the prevalence of Genetic Obesity?
The estimated prevalence of Genetic Obesity is approximately 42000.0 per 100,000 population.
Deep-dive into Genetic Obesity
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis